95 related articles for article (PubMed ID: 29539256)
1. LPA or GeneXpert in the diagnosis of multidrug-resistant tuberculosis.
Mindru R; Spinu V; Popescu O
Pneumologia; 2016; 65(2):76-80. PubMed ID: 29539256
[TBL] [Abstract][Full Text] [Related]
2. Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.
Ershova JV; Volchenkov GV; Somova TR; Kuznetsova TA; Kaunetis NV; Kaminski D; Demikhova OV; Chernousova LN; Vasilyeva IA; Kerr EM; Cegielski JP; Kurbatova EV
BMC Infect Dis; 2020 Jul; 20(1):543. PubMed ID: 32711457
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of the Xpert MTB/RIF assay for tuberculous lymphadenitis on fine needle aspirates from Ethiopia.
Biadglegne F; Mulu A; Rodloff AC; Sack U
Tuberculosis (Edinb); 2014 Sep; 94(5):502-5. PubMed ID: 24931451
[TBL] [Abstract][Full Text] [Related]
4. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
[TBL] [Abstract][Full Text] [Related]
5. Performance evaluation of Xpert MTB/RIF in a moderate tuberculosis incidence compared with TaqMan MTB and TRCRapid M.TB.
Tsuyuguchi K; Nagai H; Ogawa K; Matsumoto T; Morimoto K; Takaki A; Mitarai S
J Infect Chemother; 2017 Feb; 23(2):101-106. PubMed ID: 27919693
[TBL] [Abstract][Full Text] [Related]
6. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.
Rabna P; Ramos J; Ponce G; Sanca L; Mané M; Armada A; Machado D; Vieira F; Gomes VF; Martins E; Colombatti R; Riccardi F; Perdigão J; Sotero J; Portugal I; Couto I; Atouguia J; Rodrigues A; Viveiros M
PLoS One; 2015; 10(5):e0127536. PubMed ID: 26017968
[TBL] [Abstract][Full Text] [Related]
7. Systematic screening for drug-resistant tuberculosis with Xpert(®) MTB/RIF in a referral hospital in Cambodia.
Lorent N; Kong C; Kim T; Sam S; Thai S; Colebunders R; Rigouts L; Lynen L
Int J Tuberc Lung Dis; 2015 Dec; 19(12):1528-35. PubMed ID: 26614197
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
[TBL] [Abstract][Full Text] [Related]
9. Are WHO approved nucleic acid amplification tests causing large-scale "false identification" of rifampicin-resistant tuberculosis?: Programmatic experience from south india.
Sanker P; Ambika AP; Santhosh VT; Kottuthodi RP; Balakrishnan R; Mrithunjayan SK; Moosan H
Int J Mycobacteriol; 2017; 6(1):21-26. PubMed ID: 28317800
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic yield of Bronchoalveolar Lavage gene Xpert in smear-negative and sputum-scarce pulmonary tuberculosis.
Khalil KF; Butt T
J Coll Physicians Surg Pak; 2015 Feb; 25(2):115-8. PubMed ID: 25703755
[TBL] [Abstract][Full Text] [Related]
11. Effects of Xpert
Beste J; Mutaquiha C; Manhiça I; Jose B; Monivo C; Faria M; Creswell J; Codlin AJ; Michel C; Wagenaar B; Gloyd S; Cowan J
Int J Tuberc Lung Dis; 2018 Nov; 22(11):1358-1365. PubMed ID: 30355417
[TBL] [Abstract][Full Text] [Related]
12. Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia.
Skenders GK; Holtz TH; Riekstina V; Leimane V
Int J Tuberc Lung Dis; 2011 Nov; 15(11):1546-52, i. PubMed ID: 22008771
[TBL] [Abstract][Full Text] [Related]
13. Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia.
Tadesse M; Aragaw D; Dimah B; Efa F; Abebe G
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S48-S49. PubMed ID: 28043605
[TBL] [Abstract][Full Text] [Related]
14. Has universal screening with Xpert® MTB/RIF increased the proportion of multidrug-resistant tuberculosis cases diagnosed in a routine operational setting?
Naidoo P; Dunbar R; Caldwell J; Lombard C; Beyers N
PLoS One; 2017; 12(2):e0172143. PubMed ID: 28199375
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of a new model for early detection of patients with multidrug-resistant tuberculosis in a developed setting of eastern China.
Liu Z; Pan A; Wu B; Zhou L; He H; Meng Q; Chen S; Pang Y; Wang X
Trop Med Int Health; 2017 Oct; 22(10):1328-1333. PubMed ID: 28746979
[TBL] [Abstract][Full Text] [Related]
16. Direct rapid diagnosis of rifampicin-resistant M. tuberculosis infection in clinical samples by line probe assay (INNO LiPA Rif-TB).
Cirillo DM; Piana F; Frisicale L; Quaranta M; Riccabone A; Penati V; Vaccarino P; Marchiaro G
New Microbiol; 2004 Jul; 27(3):221-7. PubMed ID: 15460524
[TBL] [Abstract][Full Text] [Related]
17. Assessing the utility of Xpert(®) MTB/RIF as a screening tool for patients admitted to medical wards in South Africa.
Heidebrecht CL; Podewils LJ; Pym AS; Cohen T; Mthiyane T; Wilson D
Sci Rep; 2016 Jan; 6():19391. PubMed ID: 26786396
[TBL] [Abstract][Full Text] [Related]
18. A novel automatic molecular test for detection of multidrug resistance tuberculosis in sputum specimen: A case control study.
Li Q; Ou XC; Pang Y; Xia H; Huang HR; Zhao B; Wang SF; Zhao YL
Tuberculosis (Edinb); 2017 Jul; 105():9-12. PubMed ID: 28610793
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic utility of line probe assays for multidrug-resistant tuberculosis.
Ninan MM; Gowri M; Christopher DJ; Rupali P; Michael JS
Pathog Glob Health; 2016; 110(4-5):194-9. PubMed ID: 27499239
[TBL] [Abstract][Full Text] [Related]
20. Meta-narrative review of molecular methods for diagnosis and monitoring of multidrug-resistant tuberculosis treatment in adults.
Mbelele PM; Mohamed SY; Sauli E; Mpolya EA; Mfinanga SG; Addo KK; Heysell SK; Mpagama SG
Int J Mycobacteriol; 2018; 7(4):299-309. PubMed ID: 30531026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
